Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stefano Lucherini"'
Autor:
Amir A. Tahami Monfared, Mitesh Desai, Robert Hughes, Stefano Lucherini, Yunni Yi, Richard Perry
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 521-534 (2020)
Abstract Introduction Dementia with Lewy bodies (DLB) is the third most common type of dementia after Alzheimer’s disease (AD) and vascular dementia. Treatment is targeted at specific disease manifestations/symptoms. While donepezil is approved for
Externí odkaz:
https://doaj.org/article/a69dec89e88443a8b87553e9a763f480
Autor:
Ruben Mujica-Mota, Jo Varley-Campbell, Irina Tikhonova, Chris Cooper, Ed Griffin, Marcela Haasova, Jaime Peters, Stefano Lucherini, Juan Talens-Bou, Linda Long, David Sherriff, Mark Napier, John Ramage, Martin Hoyle
Publikováno v:
Health Technology Assessment, Vol 22, Iss 49 (2018)
Background: Neuroendocrine tumours (NETs) are a group of heterogeneous cancers that develop in cells in the diffuse neuroendocrine system. Objectives: To estimate the clinical effectiveness of three interventions [everolimus (Afinitor®; Novartis Int
Externí odkaz:
https://doaj.org/article/ef0ab2f5847e47759e8ad1e5af575ec7
Autor:
Harriet Doig, Catherine Weadick, Iseult Browne, Nirav Nagda, Stefano Lucherini, Austin G. Duffy, Elizabeth Bell, Aileen Murphy, Eoin Bradley
Publikováno v:
Journal of Clinical Oncology. 39:e13593-e13593
e13593 Background: In Ireland, the incidence of cancer was estimated to be 30,272 in 2018 with approximately 9,621 deaths. Over the next five years, the incidence of all cancers is expected to increase by 39% in males and 27% in females. Despite chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a85a053a21efeb4c5607800edd7ee8e8
https://doi.org/10.1200/jco.2021.39.15_suppl.e13593
https://doi.org/10.1200/jco.2021.39.15_suppl.e13593
Autor:
Marcela Haasova, Martin Hoyle, Mark Napier, Ed Griffin, John Ramage, Irina A Tikhonova, Chris Cooper, Juan Talens-Bou, David Sherriff, Ruben Mujica-Mota, Linda Long, Jaime Peters, Stefano Lucherini, Jo Varley-Campbell
Publikováno v:
Health Technology Assessment, Vol 22, Iss 49 (2018)
BackgroundNeuroendocrine tumours (NETs) are a group of heterogeneous cancers that develop in cells in the diffuse neuroendocrine system.ObjectivesTo estimate the clinical effectiveness of three interventions [everolimus (Afinitor®; Novartis Internat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e23193dd0e145cd81b04c6130941cbf
https://pubmed.ncbi.nlm.nih.gov/30209002
https://pubmed.ncbi.nlm.nih.gov/30209002